One afternoon in July, deep within the labyrinthine halls of
Deciphera Pharmaceuticals Initiates a Phase 1b/2 Clinical Trial of Rebastinib in Combination with Paclitaxel to Assess Safety, Tolerability, Pharmacokinetics and Efficacy in Patients with Advanced or Metastatic Solid Tumors
WALTHAM, Mass.–(BUSINESS WIRE)–Oct. 23, 2018– Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH), a
Lung Cancer Risk Tied to Common Blood Pressure Drugs, ACE Inhbitors
WEDNESDAY, Oct. 24, 2018 — Millions of Americans take angiotensin-converting
Researchers develop new devices to test retinal cells
Researchers at Utah State University have developed new devices to
Research finds savvy savers are less likely to become impulsive spenders
People who have greater self-control and stronger saving habits are
Why washing your hands well is so important to protect your family from the flu
During my second year of graduate school, I moved in
How substance use affects adherence to PrEP among gay and bisexual men
Research has shown that drug and alcohol use interferes with
Flavoured capsule cigarettes pose a threat to smokefree goals
New research from ASPIRE2025, a University of Otago research theme,
Would you zap your brain to improve your memory?
Using a few wires and sponges, in ordinary homes around
Belly way with the Keto diet! Thus, the effective No-Carb diet works
The ketogenic diet is stroking carbohydrates largely, so almost No